日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients

一项关于 p38 MAPK 抑制剂 SB-681323 对 COPD 患者炎症血液生物标志物影响的随机、安慰剂对照研究

Dave Singh, Lucy Smyth, Zoe Borrill, Lisa Sweeney, Ruth Tal-Singer

Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers

慢性阻塞性肺病血管功能障碍的机制及新型可溶性环氧化物水解酶抑制剂对吸烟者的影响

Lucy Yang, Joseph Cheriyan, David D Gutterman, Ruth J Mayer, Zsuzsanna Ament, Jules L Griffin, Aili L Lazaar, David E Newby, Ruth Tal-Singer, Ian B Wilkinson